World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT04113915
Date of registration: 01/10/2019
Prospective Registration: Yes
Primary sponsor: Safaa AA Khaled
Public title: Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy
Scientific title: Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy
Date of first enrolment: November 2019
Target sample size: 150
Recruitment status: Not yet recruiting
URL:  https://clinicaltrials.gov/show/NCT04113915
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Contacts
Name:     Safaa A Khaled, Ass. Prof.
Address: 
Telephone: 01064170058
Email: safaakhaled2003@gmail.com
Affiliation: 
Name:     Shymaa Mohamed Nageeb, MD
Address: 
Telephone:
Email:
Affiliation:  Shymaanageeb1993@gmail.com
Name:     Mohammad Elyamany, Prof.
Address: 
Telephone:
Email:
Affiliation:  Yamany1@yahoo.com
Key inclusion & exclusion criteria

Inclusion Criteria:

- ITP patients received triple therapy or steroids only more than 18 years old

Exclusion Criteria:

All ITP patient less than 18 years old or treated with other regimens except triple therapy
or steroids.

Patients with other bleeding disorders ITP patients with known viral hepatitis B & C
infection before triple therapy



Age minimum: 18 Years
Age maximum: 75 Years
Gender: All
Health Condition(s) or Problem(s) studied
ITP - Immune Thrombocytopenic Purpura
Viral Hepatitis
Intervention(s)
Drug: Steroids
Drug: triple therapy
Primary Outcome(s)
To estimate frequency of viral HB & C infection in ITP patients who received triple therapy in comparison with another group treated with steroids and risk factors affecting infection [Time Frame: 1 year]
Secondary Outcome(s)
1-To assess preventive measures of viral HB& C infection in the hematology ward 2-to asses effect of viral hepatitis b,c on clinical picture , response to treatment and side effects in ITP patients received triple therapy [Time Frame: 1year]
Secondary ID(s)
Viral hepatitis in ITP
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history